Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Prestige international sales jump; P&G settles Whitestrips infringement case; BlueOcean targets Indian omega-3 market; ViaDerma shop its dual carrier transdermal delivery; unapproved drugs make prostate, rosacea claims; and more industry news.
You may also be interested in...
Supplement Firms Launch New Brands, But Charged With Same Violations By FTC
Firms allegedly made false claims for four products labeled as supplements they launched since 2018 settlement. “Brazenly ignoring the Court’s order barring them from making unsubstantiated claims,” firms “have continued promoting their products with outrageous claims,” FTC contends.
'Free Trial' Plus False Claims Equals More FTC Enforcement In Supplement Market
FTC on consecutive days announced court order closing a California business allegedly charging consumers for products and enrolling them in negative-option continuity plans without their consent after they responded to bogus free trial online offers, and started mailing 16,596 checks totaling more than $750,000 to consumers who bought deceptively marketed supplements from a Maine firm that also lured customers with a free trial pitch.
FTC Curbs Another 'Free' Ride: Health And Wellness Industry News
Health Research Laboratories agrees to settle an FTC complaint alleging false "free" offers on top of bogus health claims; reports that biotin can interfere with certain lab tests are reminders for consumers to tell doctors about supplements they use, says CRN; kratom group asks FDA and states "to tone down their overheated rhetoric about the non-opiate botanical"; and health and wellness recalls.